Patty Gille started experiencing symptoms that affected her daily life, and she immediately felt something was off. “My legs ...
Parkinson’s disease ranks second among the most common age-related neurodegenerative brain diseases. Alzheimer’s is first.
In April 2026, XellSmart officially launches its multicenter Phase II registrational clinical trial of the "Clinical-Grade, Allogeneic, Off-the-Shelf, iPSC-Derived, Dopaminergic Neural Progenitor Cell ...
The 'America's Got Talent' host and his wife discuss a new FDA-approved treatment that has given them hope in Rebecca's ...
Combining medication with physical therapy in the early stages of Parkinson’s disease can significantly slow its progression, according to ...
Researchers at the University of Miami Miller School of Medicine are exploring stem cell treatments that could replace lost ...
Cala announced today that it received FDA clearance for its kIQ Plus next-generation wearable neurostimulation device.
April is Parkinson's Awareness Month, a time to bring awareness to Parkinson's Disease and about why early intervention is ...
Despite clear clinical guidelines, many Parkinson's disease patients in India are being referred too late for Deep Brain ...
A study in Nature Microbiology shows gut bacteria can hinder Parkinson's drugs. COMT inhibitors may boost microbes that break ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results